Evidence map›Paper›PMID 36615640›Full record

ArticleMolecules (Basel, Switzerland)2023

Study of Polonium (

Paweł Rudnicki-Velasquez, Alicja Boryło, Marcin Kaczor, Jarosław Wieczorek, Jarosława Rutkowska

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paweł Rudnicki-VelasquezInstitute of Human Nutrition Sciences, Faculty of Human Nutrition, Warsaw University of Life Sciences (WULS-SGGW), Nowoursynowska St. 159c, 02-776 Warsaw, Poland.ORCID 0000-0003-0368-0112
Alicja BoryłoFaculty of Chemistry, University of Gdańsk, Wita Stwosza Str. 63, 80-308 Gdańsk, Poland.
Marcin KaczorFaculty of Chemistry, University of Gdańsk, Wita Stwosza Str. 63, 80-308 Gdańsk, Poland.ORCID 0000-0003-4171-9575
Jarosław WieczorekFaculty of Chemistry, University of Gdańsk, Wita Stwosza Str. 63, 80-308 Gdańsk, Poland.
Jarosława RutkowskaInstitute of Human Nutrition Sciences, Faculty of Human Nutrition, Warsaw University of Life Sciences (WULS-SGGW), Nowoursynowska St. 159c, 02-776 Warsaw, Poland.ORCID 0000-0001-8026-4900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at assessing the activity concentration and the annual effective dose of polonium-210 (210Po) in fruit wines derived from four locations in Poland (Warmian−Masurian, Podlaskie, Lubelskie and Małopolskie voivodeships). The fruit wines differed significantly (p < 0.05) in 210Po activity depending on the production site, with the Małopolskie site having the highest activity (61.4−221.4 mBq/L) and the Podlaskie having the lowest (3.5−97.1 mBq/L). The site differentiation was due to environmental conditions—soil parameters (uranium concentration), precipitations and terrain characteristics, e.g., the proximity of the lakes. The increased activity concentration of 210Po in samples from Małopolska compared with the other sites probably derived from the environment polluted with aqueous wastes and particulate air pollution. The annual effective dose due to the ingestion of fruit wines ranged from 0.112 to 1.214 µSv/year. These levels of exposure are safe according to the WHO criterion (0.1 mSv per year for ingestion) and to the IAEA reference level for public exposure including food (1 mSv per year). Summing up, the data obtained provide information on the activity concentration of 210Po in fruit wines and increase databases on the natural radioactivity of foodstuffs. Future work is needed to examine 210Po activity in samples from all vineyard regions in Poland.

Indexed as

PoloniumRadiation MonitoringWineFruitPolandPoloniumPolonium-210annual effective dosefruit winesgeographic provenancepolonium-210radioactivity

Identifiers

PMID36615640
PMCPMC9824190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.